Both in Pharmaceuticals
Pliant Therapeutics vs Annovis Bio
Over the past year PLRX returned −47.1% and ANVS returned −36.0%; their daily moves had a correlation of 0.22.
PLRX −47.1% ANVS −36.0%Growth of $1, one year, split-adjusted
| Metric | PLRX | ANVS |
|---|---|---|
| Price | $0.8518 | $1.21 |
| Market cap | $52.7M | $51.6M |
| Today | −1.03% | +11.01% |
| 1 month | −17.3% | +2.5% |
| 6 months | −30.7% | −49.6% |
| Year to date | −30.2% | −65.0% |
| 1 year | −49.0% | −40.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $158.1M | $18.7M |
| Dividend yield | — | — |
| Volatility (60d) | 50.5% | 79.3% |
| Short % of float | 9.6% | 15.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).